Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Rivastigmine in the Treatment of Postoperative Delirium: a Pilot Clinical Trial

NCT00835159 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.

NCT NCT00835159
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00835159 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Rivastigmine in the Treatment of Postoperative Delirium: a Pilot Clinical Trial
Lead sponsor
NYU Langone Health
Phase
Phase 4
Overall status
Completed
Start date
December 31, 2008
Completion date
October 31, 2010
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

delirium, postoperative cognitive dysfunction